Lipidil tablets 80 mg (fenofibrate) for hyperlipidemia

Are Lipidil tablets 80 mg (fenofibrate) effective for hyperlipidemia?

Package details: 100 tablets

Active components: fenofibrate

Therapeutic effect: treatment of hyperlipidemia

Lipidil Tablets for Hyperlipidemia Treatment

Lipidil tablets contain fenofibrate, a lipid-regulating medicine used for hyperlipidemia treatment, including familial hyperlipidemia. Hyperlipidemia means that the level of fats in the blood is higher than recommended. These fats may include cholesterol, triglycerides, also called neutral fat, or both.

Fenofibrate tablets are mainly used when the treatment goal is to improve the lipid profile more broadly, not only by lowering one type of blood fat. Lipidil helps reduce triglycerides and cholesterol while supporting an increase in HDL cholesterol, often called good cholesterol.

How Lipidil Works in the Body

The active ingredient in Lipidil is fenofibrate. It works by activating PPARα, a type of nuclear receptor involved in controlling lipid metabolism. After PPARα is activated, it helps regulate the expression of proteins that take part in breaking down, transporting, and balancing fats in the blood.

This mechanism allows Lipidil to act on several parts of lipid metabolism at the same time. It helps the body process triglycerides more efficiently, lowers excess cholesterol, and supports a healthier balance between harmful and protective lipid fractions.

What Lipidil Helps Improve

Lipidil is usually used for hyperlipidemia, including inherited forms such as familial hyperlipidemia. Its effect is not limited to one laboratory number, which is important because many patients with hyperlipidemia have several lipid abnormalities at once.

The main expected benefits include:

• lower triglyceride, or neutral fat, levels in the blood;
• reduced total cholesterol and LDL cholesterol;
• increased HDL cholesterol;
• more balanced lipid metabolism through PPARα activation;
• support for long-term control of abnormal blood fat levels.

Hyperlipidemia tabelts such as Lipidil may be considered when cholesterol and triglycerides need medical control as part of a broader treatment plan.

Evidence Supporting Fenofibrate Effectiveness

Clinical data also support the lipid-lowering effect of fenofibrate. In the scientific study Effectiveness and Safety of Fenofibrate in Routine Treatment of Patients with Hypertriglyceridemia and Metabolic Syndrome, 988 patients with high triglyceride levels were enrolled. The group was approximately evenly divided between male and female patients, and most participants also had concomitant cardiovascular disease.

After 6 months of fenofibrate therapy, the average triglyceride level decreased from 3.6 ± 1.5 mmol/L to 1.7 ± 0.58 mmol/L, which was a 50.1% reduction. This result is clinically meaningful because triglycerides are one of the main lipid targets in many patients treated with fenofibrate tablets.

The same study showed that non-HDL cholesterol decreased by 33.7%. Non-HDL cholesterol includes several atherogenic lipid fractions, so this reduction gives a broader view of improvement than LDL cholesterol alone. Total cholesterol decreased by 24.7%, while LDL cholesterol was reduced by 25.5%.

The study also reported that C-reactive protein decreased by more than 39%. C-reactive protein is not a lipid, but it is commonly used as a marker connected with inflammation in the body. This result adds useful context to the overall metabolic improvement observed during fenofibrate therapy.

Why Lipid Metabolism Matters

High cholesterol and triglyceride levels often do not cause clear symptoms, but they can still affect blood vessels over time. For this reason, hyperlipidemia treatment is usually based on blood test results and overall cardiovascular risk rather than on how a patient feels from day to day.

Lipidil is designed to improve the internal handling of fats. By acting through PPARα, it helps the body regulate proteins involved in lipid breakdown and transport. This is why fenofibrate can reduce triglycerides, lower cholesterol fractions, and increase HDL cholesterol as part of one coordinated mechanism.

Who Lipidil Is Usually Used For

Lipidil is usually used for patients diagnosed with hyperlipidemia, including familial hyperlipidemia. It may be especially relevant when triglycerides are elevated and when a more comprehensive improvement in lipid metabolism is needed.

Fenofibrate tablets may be used in patients whose blood tests show:

• high triglycerides;
• high total cholesterol;
• increased non-HDL cholesterol;
• low HDL cholesterol;
• mixed lipid abnormalities.

These effects make Lipidil a practical option within medical lipid control, especially when neutral fat reduction is an important goal.

Lipidil Tablets in Hyperlipidemia Care

Lipidil does not work as a simple fat blocker. Its action is deeper and more metabolic: fenofibrate activates PPARα and influences the expression of proteins that control how fats are processed in the body. This helps explain why one medicine can improve several lipid markers at the same time.

For patients comparing options before they buy fenofibrate, it is helpful to understand that Lipidil is not only aimed at lowering cholesterol. It also targets triglycerides and supports HDL cholesterol, making it suitable for broader lipid metabolism improvement in hyperlipidemia.

Dosage and administration: adults should take 106.6-160 mg of the active ingredient at a time, once a day, after meal. Your doctor may adjust the dosage according to the age and symptoms. However, the maximum daily dosage should not exceed 160 mg. These tablets contains 80 mg of the active ingredient in a tablet.

Patients should strictly follow the instructions for diet and exercising provided by their doctor.

Contraindications and precautions: Store in a dry cool place, out of reach of children. Do not use for pregnant or breastfeeding women. Do not use for patients with hepatic disorder, renal dysfunction or gallbladder disease.

Do not expose to sunlight or heat. If allergic symptoms occur, discontinue use.